Stock Taper
EARNINGS CALL ARCHIVE 1 CALL ON FILE
CNSP — CNS Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →

Q4 2019 Earnings Call Summary

MAR 12, 2020
REVENUE
$0
EPS
$28.32 +4820.0%
FREE CASH FLOW
-$2.5M -557.5%

No summary has been written for this call yet.